Capillary tube formation

Capillary tube formation is a complex biological process in which endothelial cells organize into a three-dimensional network of lumen-containing, tube-like structures, representing a critical stage of angiogenesis (PubMed: 19376174). While it is a fundamental physiological event, it is not a specific molecular target (such as a receptor or enzyme) but rather a phenotypic outcome or cellular behavior used frequently in pharmacological assays (NIH: PMC4871439). This process involves a coordinated sequence of cell adhesion, migration, protease activity, and differentiation, primarily driven by signaling pathways such as Vascular Endothelial Growth Factor (VEGF) and Notch (PubMed: 12359667). In clinical contexts, excessive capillary tube formation is a hallmark of tumor growth and neovascular eye diseases, whereas insufficient formation can lead to poor wound healing or ischemic tissue damage (Nature Reviews Cancer: 1471-0072). Therapeutic agents, particularly anti-angiogenic drugs like bevacizumab, are evaluated by their ability to inhibit this process, although their primary molecular targets are the growth factors or receptors that trigger it. Therefore, while "capillary tube formation" is a vital parameter in drug discovery, it refers to a biological system's response rather than a single druggable molecule.

Other names

Endothelial tube formationAngiogenesis tube formationIn vitro tube formation assayCapillary-like structure formation

Drugs typically modulate this process by inhibiting upstream growth factor signaling (e.g., VEGF/VEGFR) or disrupting cell-matrix interactions required for endothelial organization.